Accurate and fast delivery of key events and news of growing Genexine
Monthly News about Genexine
1 
Press Release
-
Sep 01, 2021Genexine Pursues Global CEO to Accelerate Growth on International Stage더보기
-
Aug 30, 2021Genexine plans to develop GX-19N as booster vaccine더보기
-
Aug 17, 2021Sales of 34.6 billion won in the first half of 2021 and operating profit of 2.7 billion won더보기
-
Jul 07, 2021COVID-19 vaccine GX-19N, phase 2/3 IND approved at Indonesia.더보기
-
May 20, 2021Genexine’s Cervical cancer therapeutic vaccine abstract released at ASCO 2021더보기
Video
Innovative biotech company GENEXINE's GX-188E, the Cervical Cancer Treatment DNA Vaccine, can save lives of patients who suffers from the late stage metastasized cervical cancer.
1 Event Calendar
| Date | Event Details |
|---|
Awards and Recognitions
-
2020Sincere tax office in Gyeonggi-do
-
2019Certification of the Excellent Laboratory for Safety Management
-
2018The Appreciation Plaque by Korea Support Committe for IVI
-
2017Excellence Brain Capability Company (K-BrainPower)
-
2017Innovative Pharmaceutical Company
